JPH02200683A - Tetrabromocyclopenta(b)benzofuran derivative and production thereof - Google Patents

Tetrabromocyclopenta(b)benzofuran derivative and production thereof

Info

Publication number
JPH02200683A
JPH02200683A JP1898589A JP1898589A JPH02200683A JP H02200683 A JPH02200683 A JP H02200683A JP 1898589 A JP1898589 A JP 1898589A JP 1898589 A JP1898589 A JP 1898589A JP H02200683 A JPH02200683 A JP H02200683A
Authority
JP
Japan
Prior art keywords
formula
compound
benzofuran
tetrabromocyclopenta
cis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP1898589A
Other languages
Japanese (ja)
Other versions
JP2782756B2 (en
Inventor
Kiyotaka Ono
大野 清隆
Hiroshi Nagase
博 長瀬
Hisanobu Wakita
尚宜 脇田
Hideo Yoshihara
秀夫 吉原
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Toray Industries Inc
Original Assignee
Toray Industries Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Toray Industries Inc filed Critical Toray Industries Inc
Priority to JP1898589A priority Critical patent/JP2782756B2/en
Publication of JPH02200683A publication Critical patent/JPH02200683A/en
Application granted granted Critical
Publication of JP2782756B2 publication Critical patent/JP2782756B2/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Abstract

NEW MATERIAL:The compound of formula I. USE:A key synthetic intermediate for 5,6,7-trinor-4,8-inter-m-phenylene PGI2 derivative useful as an antithrombotic agent, antiulcer agent and hypotensor. PREPARATION:The objective compound of formula I is produced by brominating 3a, 8b-cis-dihydro-3H-cyclopenta[b]benzofuran of formula II optionally in the presence of a Friedel-Crafts catalyst. The compound of formula II used as a starting raw material can be produced by dissolving the compound of formula III in a solvent, adding dried metallic magnesium to the solution and cyclizing the resultant di-Grignard reagent by the addition of a catalytic amount of a metal reagent.

Description

【発明の詳細な説明】 [産業上の利用分野] 本発明は、式(I)で示される B「 テトラブロモシクロペンタ〔b〕ベンゾフラン誘導体。[Detailed description of the invention] [Industrial application field] The present invention is represented by formula (I) B" Tetrabromocyclopenta[b]benzofuran derivative.

(2)  式(If)で示される Br  Br テトラブロモシクロペンタ(b)ベンゾフラン誘導体お
よびその製造法に関する。
(2) The present invention relates to a Br Br tetrabromocyclopenta(b) benzofuran derivative represented by formula (If) and a method for producing the same.

[従来の技術] 式(I)テトラブロモシクロペンタ(b)ベンゾフラン
誘導体を脱ブロム化することにより容易に得られる式(
m)の Br 3a、8b−シス−ジヒドロ−3H−シクロペンタ〔b
〕ベンゾフランをブロモ化することを特徴3a、  8
b−シスージヒドo−3H−5.7−ジプロモシクロペ
ンタ(b)ベンゾフランは医薬品、特に抗血栓剤、抗潰
瘍剤、血圧降下剤として有用な5,6.7−4リノルー
4,8−インターmフェニレンPG12誘導体(■)(
特開昭5636477号公報、特開昭58−12477
8号公報他)の鍵合成中間体で、ある(特開昭57−1
44277号公報他)。
[Prior art] Formula (I) tetrabromocyclopenta(b) easily obtained by debrominating a benzofuran derivative (
m) Br 3a,8b-cis-dihydro-3H-cyclopenta[b
] Characteristic 3a, 8 brominating benzofuran
b-cissu dihydro-3H-5,7-dipromocyclopenta(b)benzofuran is a 5,6,7-4 linoleum-4,8-inter- m-phenylene PG12 derivative (■) (
JP-A-5636477, JP-A-58-12477
8, etc.), and is a key synthesis intermediate of
44277, etc.).

従来、(m)の製造法として、3,5−シスビス(2,
4,6−)リブロモフェノキシ)シクロペンテン(v)
とグリニヤール試薬とを反応させて、ハロゲン金属交換
を行なった後、金属触媒を加えて環化反応を生起させて
いた(特開昭57144277号公報)。
Conventionally, as a method for producing (m), 3,5-cisbis(2,
4,6-)ribromophenoxy)cyclopentene (v)
After reacting with a Grignard reagent to perform halogen metal exchange, a metal catalyst was added to cause a cyclization reaction (Japanese Patent Laid-Open No. 57144277).

0υ [発明が解決しようとする課題] かかる従来技術による場合、次のような問題点がある。0υ [Problem to be solved by the invention] This conventional technique has the following problems.

(1)  (III)は沸点が高いため蒸留精製ができ
ない。また、環化反応の収率がよくないため再結晶精製
が困難であり、(■)の精製にカラムクロマトグラフィ
ーを用いている。従って、(I[[)の精製に多大の時
間を要し、(III)の製造コスト高の原因となる。
(1) (III) cannot be purified by distillation due to its high boiling point. In addition, recrystallization purification is difficult because the yield of the cyclization reaction is poor, so column chromatography is used to purify (■). Therefore, it takes a lot of time to purify (I[[), which causes an increase in the manufacturing cost of (III).

(2)  環化反、応の収率がハロゲン金属交換反応に
用いるグリニヤール試薬の当量に大きく依存し、当量の
わずかな違いで収率の低下を招く。また、その最適当量
は、3,5−シス−ビス(2,4゜6−ドリブロモフエ
ノキシ)シクロペンテン(V)の純度によって異なり、
収率の再現性が得られないことがある。
(2) The yield of the cyclization reaction and the reaction largely depend on the equivalent weight of the Grignard reagent used in the halogen metal exchange reaction, and a slight difference in the equivalent weight causes a decrease in the yield. In addition, the optimum equivalent amount varies depending on the purity of 3,5-cis-bis(2,4゜6-dribromophenoxy)cyclopentene (V),
Yields may not be reproducible.

[課題を解決するための手段] 本発明者らは、かかる従来技術の欠点を克服した(II
I)の工業的製法について鋭意検討した結果、式(II
)で示される 3a、8b−シス−ジヒドロ−3H−シクロペンタ(b
)ベンゾフランから新規化合物である(4)を経由して
、高収率で容易に、しかも再現性よく得る方法を見い出
し、本発明に至った。
[Means for Solving the Problems] The present inventors have overcome the drawbacks of the prior art (II
As a result of intensive study on the industrial production method of formula (II),
) 3a,8b-cis-dihydro-3H-cyclopenta(b
) We have discovered a method for obtaining the new compound (4) from benzofuran easily and in high yield with good reproducibility, leading to the present invention.

すなわち本発明は、式(I)で示されるテトラブロモシ
クロペンタ(b)ベンゾフラン誘導体およびその製造法
である。
That is, the present invention is a tetrabromocyclopenta(b) benzofuran derivative represented by formula (I) and a method for producing the same.

本発明化合物(I)は、次式の(IA)および(IB)
を含む。
The compound (I) of the present invention is represented by (IA) and (IB) of the following formula:
including.

Br   Br              Br  
、Br(IA)             (rB)本
発明は、具体的には通常以下の如き条件下に行なう。
Br Br Br
, Br(IA) (rB) Specifically, the present invention is usually carried out under the following conditions.

まず本発明の原料である(Il、)は次の方法により容
易に得ることができる。すなわち、特開昭57−144
233の反応条件に従って合成できる(VI)を溶媒に
溶かして、乾燥した金属マグネシウムに加えることによ
りジグリニャール試薬を発生させる。その後、触媒量の
金属試薬を加え、環化させて(II)を得る。環化反応
は、高収率で再現性よく進行し、しかも(Il、)は蒸
留が可能であるため単離精製が容易である。
First, (Il,), which is a raw material of the present invention, can be easily obtained by the following method. That is, JP-A-57-144
(VI), which can be synthesized according to the reaction conditions of No. 233, is dissolved in a solvent and added to dry magnesium metal to generate a digrignard reagent. Thereafter, a catalytic amount of metal reagent is added and cyclization is performed to obtain (II). The cyclization reaction proceeds with high yield and good reproducibility, and since (Il,) can be distilled, it is easy to isolate and purify.

(VI) (fi) 本発明化合物(I)は、(II)を溶媒に溶かして臭素
を加えることにより製造することができる。
(VI) (fi) Compound (I) of the present invention can be produced by dissolving (II) in a solvent and adding bromine.

用いる溶媒としては、ジクロロメタン、クロロホルム、
四塩化炭素等の塩素系溶媒や二硫化炭素、酢酸、シクロ
ヘキサンが通常用いられるが、なかでもジクロロメタン
、クロロホルムが好ましい。
The solvent used is dichloromethane, chloroform,
Chlorinated solvents such as carbon tetrachloride, carbon disulfide, acetic acid, and cyclohexane are commonly used, and dichloromethane and chloroform are particularly preferred.

臭素の当量はフリーデルクラフッ触媒を用いるか否かに
よって異なる。すなわち、触媒を用いない場合には、臭
素の当量としては3〜10当量が用いられるが、なかで
も4〜6当量が好ましい。触媒を用いる場合には、臭素
の当量としては3〜6当量が用いられるが、なかでも3
〜3.2当量が好ましい。フリーゾルタラフッ触媒とし
ては、鉄、塩化第二鉄、臭化第二鉄、塩化アルミニウム
、臭化アルミニウム、塩化亜鉛、塩化アンチモン(m)
等が通常用いられるが、なかでも鉄、臭化アルミニウム
が好ましい。触媒の当量としては00OO1〜0.5当
量が用いられるが、なかでも0.007〜0.015当
量が好ましい。
The equivalent amount of bromine varies depending on whether a Friedel-Craft catalyst is used or not. That is, when a catalyst is not used, the equivalent amount of bromine used is 3 to 10 equivalents, with 4 to 6 equivalents being particularly preferred. When using a catalyst, the equivalent amount of bromine used is 3 to 6 equivalents, especially 3 to 6 equivalents.
~3.2 equivalents are preferred. Free-sol cod fluoride catalysts include iron, ferric chloride, ferric bromide, aluminum chloride, aluminum bromide, zinc chloride, and antimony chloride (m).
etc. are commonly used, and among these, iron and aluminum bromide are preferred. As the equivalent of the catalyst, 00OO1 to 0.5 equivalent is used, and 0.007 to 0.015 equivalent is particularly preferred.

反応温度としては、触媒を用いない場合には20〜10
0℃が用いられ、なかでも20〜60℃が好ましい。触
媒を用いた場合には0〜30°Cが用いられる。
The reaction temperature is 20 to 10 when no catalyst is used.
0°C is used, with 20-60°C being preferred. When a catalyst is used, a temperature of 0 to 30°C is used.

反応時間としては、触媒を用いずに行なった場合には1
0分〜1週間が用いられ、なかでも臭素4当量では12
時間〜1日が好ましく、臭素5当量以上では10分〜3
時間が好ましい。触媒を用いた場合には1分〜1週間が
用いられるが、なかでも30分〜1日が好ましい。
The reaction time is 1 when carried out without using a catalyst.
0 minutes to 1 week are used, especially for 4 equivalents of bromine, 12
1 hour to 1 day is preferable, and if the amount of bromine is 5 equivalents or more, 10 minutes to 3 hours is preferable.
time is preferable. When a catalyst is used, a time of 1 minute to 1 week is used, and a time of 30 minutes to 1 day is particularly preferred.

その他の反応条件としては、遮光下で反応を行なった方
が好ましいが、これに限るものではない。
As for other reaction conditions, it is preferable to carry out the reaction under light shielding, but the conditions are not limited thereto.

(I)の単離方法として、再結晶、シリカゲルカラムク
ロマトグラフィーが用いられるが、反応は定量的に進行
するため、未精製のまま次の反応に供することも可能で
ある。
Recrystallization and silica gel column chromatography are used to isolate (I), but since the reaction proceeds quantitatively, it is also possible to use it in the next reaction in an unpurified state.

本発明化合物(I)は、例えばチオ硫酸ナトリウム、硫
化ナトリウムまたは亜鉛等の脱ブロム化剤により、還元
的に脱ブロム化することにより容易に(m)にすること
ができる; 式(III)の化合物から、例えば特開昭57−144
277号公報、特開昭58−124778号公報等に記
載の方法により、医薬品として有用な式(TV)の5.
6.7−)ジノル−4,8−インター とができる。
The compound (I) of the present invention can be easily converted to (m) by reductive debromination with a debrominating agent such as sodium thiosulfate, sodium sulfide or zinc; From compounds, for example, JP-A-57-144
No. 277, JP-A No. 58-124778, etc., the formula (TV) useful as a pharmaceutical is prepared by the method described in 5.
6.7-) dinor-4,8-inter.

[実 施 例コ 以下、本発明を実施例により具体的に説明するが、本発
明はこれらに限定されるものではない。
[Examples] Hereinafter, the present invention will be specifically explained with reference to Examples, but the present invention is not limited thereto.

参考例1 乾燥したマグネシウム1.  3g (53.  5m
mol)に乾燥THF10mlを加えた後、3.5−シ
スビス(2−ブロモフェノキシ)シクロペンテン10g
 (24. 4mmol)をTHF70mlに溶かした
ものの一部を加えた。これを加温してグリニヤール反応
を生起させた後、残りのTHF溶液を加えて室温で撹拌
した。次に、乾燥したマグネシウム65、2g (2.
68川o1 )に上記の反応液を加え、更に乾燥THF
0.5ffを加えた後、3,5ビス(2−ブロモフェノ
キシ)シクロペンテン500g (1. 22mol 
)をTHF3.5αに溶解させたものを徐々に加えた。
Reference example 1 Dry magnesium 1. 3g (53.5m
After adding 10 ml of dry THF to mol), 10 g of 3.5-cisbis(2-bromophenoxy)cyclopentene
(24.4 mmol) dissolved in 70 ml of THF was added. After heating this to cause a Grignard reaction, the remaining THF solution was added and stirred at room temperature. Next, 65.2 g of dried magnesium (2.
Add the above reaction solution to 68 river o1) and add dry THF.
After adding 0.5ff, 500g (1.22mol) of 3,5bis(2-bromophenoxy)cyclopentene
) dissolved in THF3.5α was gradually added.

加え終わった後、50℃で1時間加熱した後水冷した。After the addition was completed, the mixture was heated at 50° C. for 1 hour and then cooled with water.

次にCu11 1、  6g (60.  9+n+n
ol)を加え、40℃で1時間加熱した後水冷した。反
応液に3NNaOH水溶液0.9αを加え、ハイフロス
−パーセルを用いて沢過した。THF2.5Qで濾過し
た固体を洗浄後、P液を濃縮した。濃縮液をシクロヘキ
サン1uで4回抽出し、有機層を2NNaOH水溶液0
.2iで2回、飽和食塩水0.1αで3回洗浄後、無水
硫酸マグネシウムで乾燥した。抽出洗浄時に界面が不明
確な場合には、適宜ハイフロス−パーセルを用いてt濾
過した。そして、硫酸マグネシウムをP別技、P液の有
機層を濃縮した。
Next, Cu11 1, 6g (60. 9+n+n
ol) was added, heated at 40°C for 1 hour, and then cooled with water. 0.9α of a 3N NaOH aqueous solution was added to the reaction solution, and the mixture was filtered using Hyfloth Parcel. After washing the filtered solid with THF2.5Q, the P solution was concentrated. The concentrated solution was extracted 4 times with 1 u of cyclohexane, and the organic layer was extracted with 2N NaOH aqueous solution 0.
.. After washing with 2i twice and three times with saturated saline 0.1α, it was dried over anhydrous magnesium sulfate. If the interface was unclear during extraction and washing, t-filtration was performed using Hyfloth Purcel as appropriate. Then, magnesium sulfate was added to P and the organic layer of the P solution was concentrated.

更に3,5−シス−ビス(2−ブロモフェノキシ)シク
ロペンテン816g (1.99mol )を用いて同
様の操作を行ない、2つ合わせて蒸留した。
Further, the same operation was carried out using 816 g (1.99 mol) of 3,5-cis-bis(2-bromophenoxy)cyclopentene, and the two were distilled together.

収量 377、0g    収率 73.7%b.p.
   77、8〜78.8°C10.1闘HgNMR(
CDC13)  δ: 2.80  (IHS dd、J=2. 2.0.5t
(z) 、2.82  (IHS dd、J=5.2.
0、 5Hz)  、4. 35  (IH,d、J=
7゜8Hz)  、5.43  (IH,dddS J
=7゜8.5.2.2. 2Hz)  、5. 71 
 (2H。
Yield: 377.0g Yield: 73.7%b. p.
77, 8-78.8°C 10.1% HgNMR (
CDC13) δ: 2.80 (IHS dd, J=2.2.0.5t
(z), 2.82 (IHS dd, J=5.2.
0, 5Hz), 4. 35 (IH, d, J=
7゜8Hz), 5.43 (IH, dddS J
=7°8.5.2.2. 2Hz), 5. 71
(2H.

s)  、6. 95  (4HS m)IR(液膜法
)νcm”−1: 3060.1602.1582 Mas s  :158  (M”) 実施例1 3a、8b−シス−ジヒドロ−3H−シクロペンタ[b
]ベンゾフラン2.0156g (12゜7mg+ol
)をジクロロメタン20m1に溶かし氷冷した後、臭素
3. 9ml (76、2mmol)をゆっくり加えた
。室温で1時間撹拌した後、反応溶液を氷冷した飽和炭
酸水素ナトリウム水溶液100m1に加えた。撹拌しな
がら、チオ硫酸ナトリウム4゜7gを水10m1に溶か
したものを徐々に加えた。
s), 6. 95 (4HS m) IR (liquid film method) νcm"-1: 3060.1602.1582 Mass: 158 (M") Example 1 3a,8b-cis-dihydro-3H-cyclopenta[b
]Benzofuran 2.0156g (12゜7mg+ol
) was dissolved in 20 ml of dichloromethane and cooled on ice, and 3. 9 ml (76, 2 mmol) was added slowly. After stirring at room temperature for 1 hour, the reaction solution was added to 100 ml of ice-cooled saturated aqueous sodium hydrogen carbonate solution. While stirring, 4.7 g of sodium thiosulfate dissolved in 10 ml of water was gradually added.

臭素の色が消えたのを確認した後、酢酸エチル50m1
で2回抽出した。有機層を飽和食塩水50m1で洗浄し
、無水硫酸ナトリウムで乾燥した。硫酸ナトリウムをP
別技、濃縮乾固し、減圧乾燥すると褐色粘性液体が得ら
れた。
After confirming that the bromine color has disappeared, add 50ml of ethyl acetate.
Extracted twice. The organic layer was washed with 50 ml of saturated brine and dried over anhydrous sodium sulfate. sodium sulfate
Separately, it was concentrated to dryness and dried under reduced pressure to obtain a brown viscous liquid.

収量 6.2725g   収率 103.8%そのう
ち10.1mgをとり、薄層クロマトグラフィー分取に
よりジアステレオマーを分離し、低極性留分として(I
A)6.4■、高極性留分として(IB)3.9mgを
得た。
Yield: 6.2725g Yield: 103.8% 10.1mg of it was taken and the diastereomers were separated by thin layer chromatography preparative separation, and as a low polar fraction (I
A) 6.4mg, and (IB) 3.9mg as a highly polar fraction were obtained.

(IA)白色結晶 m、p、   117.0〜119.0°CNMR(C
DC13)δ: 2.69〜2.78 (IH,m) 、3.11〜3.
22 (IHSm) 、4.37〜4゜43 (IH,
m) 、4.43〜4.51(IHSm) 、4.55
〜4.62 (IH。
(IA) White crystal m, p, 117.0-119.0° CNMR (C
DC13) δ: 2.69-2.78 (IH, m), 3.11-3.
22 (IHSm), 4.37~4°43 (IH,
m), 4.43-4.51 (IHSm), 4.55
~4.62 (IH.

m) 、5.52〜5.60 (IHSm)、7.32
〜7.41 (IHSm) 、7.49  (IHS 
dS J=1.95Hz)I R(KB r) νcm
 ’: 2970.1452.1258.1187.1135.
1058.992.804.7Mass(EI法、m/
e):472 (M”)高分解能マススペクトル 計算値(CHOB r 4 、M” )  :471.
7309 実測値(M”):471.7323 (IB)白色結晶 m、p、    110.0〜112.0℃NMR(C
DCI 3 )δ: 2.59〜2.70 (IHSm) 、2.97 (I
HSddd、J=15.13.5゜37.3.42Hz
) 、4.35 (IHSt。
m), 5.52-5.60 (IHSm), 7.32
~7.41 (IHSm), 7.49 (IHS
dS J=1.95Hz) I R(KB r) νcm
': 2970.1452.1258.1187.1135.
1058.992.804.7Mass (EI method, m/
e): 472 (M”) High-resolution mass spectrum calculation value (CHOB r 4 , M”): 471.
7309 Actual value (M”): 471.7323 (IB) White crystal m, p, 110.0-112.0°C NMR (C
DCI3) δ: 2.59-2.70 (IHSm), 2.97 (I
HSddd, J=15.13.5°37.3.42Hz
), 4.35 (IHSt.

J=7.82Hz) 、4.40 (IHSt。J=7.82Hz), 4.40 (IHSt.

J=5.86Hz) 、4.57〜4.64(IHSm
) 、5.46〜5.53 (IH。
J=5.86Hz), 4.57~4.64(IHSm
), 5.46-5.53 (IH.

m) 、7. 34  (IH,s) 、7. 50(
LH,d、、J=1.95Hz) IR(KB r) νctn−”: 2970.1455.1263.1161.1013.
867.812 Mass(EI法、m/e) : 472 (M” )
高分解能マススペクトル 計算値(CILH80Br 4、M” )  :471
.7309 実測値(M+):471.7349 B【 Br (IA) Br   Br (IB) 実施例2 シクロペンタ(b)ベンゾフラン 3a、8b−シス−ジヒドロ−3H−シクロペンタ(b
)ベンゾフラン100g (0,632m。
m), 7. 34 (IH,s), 7. 50(
LH, d,, J=1.95Hz) IR(KB r) νctn-”: 2970.1455.1263.1161.1013.
867.812 Mass (EI method, m/e): 472 (M”)
High-resolution mass spectrum calculation value (CILH80Br 4, M”): 471
.. 7309 Actual value (M+): 471.7349 B[ Br (IA) Br Br (IB) Example 2 Cyclopenta(b) Benzofuran 3a,8b-cis-dihydro-3H-cyclopenta(b
) Benzofuran 100g (0,632m.

1)をジクロロメタン02に溶かし、鉄353mg(6
,32mmol)を加えた後水冷した。臭素100m1
 (1,96mol )をゆっくり加え、室温で21時
間撹拌した後、反応溶液を氷冷し、炭酸水素ナトリウム
160g (1,90mol )と水IQを加えた。撹
拌しながら、チオ硫酸ナトリウム7゜8g (0,03
141101)を加えた後、水層と有機層を分液した。
1) in dichloromethane 02, 353 mg of iron (6
, 32 mmol) and then cooled with water. Bromine 100ml
(1,96 mol) was slowly added and stirred at room temperature for 21 hours, the reaction solution was cooled with ice, and 160 g (1,90 mol) of sodium hydrogen carbonate and water IQ were added. While stirring, add 7°8 g of sodium thiosulfate (0.03
141101), the aqueous layer and organic layer were separated.

水層を酢酸エチル2αで抽出し、有機層を水IQ、飽和
食塩水1uで洗浄した後、無水硫酸マグネシウムで乾燥
した。硫酸マグネシウムをP別技、濃縮乾固し、減圧乾
燥した。
The aqueous layer was extracted with ethyl acetate 2α, and the organic layer was washed with water IQ and 1 u of saturated brine, and then dried over anhydrous magnesium sulfate. Magnesium sulfate was concentrated to dryness using P and dried under reduced pressure.

収量 298.7g   収率 99.7%GC純度 
 93% 参考例2 3a、8b−シス−2,3,3a、8b−テトラヒドロ
−IH−1,2,5,7−テトラブロモシクロペンタ[
b]ベンゾフラン3.00g (6゜31 mmoりを
THFlomlと酢酸10m1の混合溶媒に溶かし、亜
鉛0.8657g (13,2m1IIol)を加えて
1時間室温で撹拌した。反応液を沢過し、P液の溶媒を
留去した。残渣に水20m1.酢酸エチル20m1を加
えて抽出した。更に水層を酢酸エチル20m1で2回抽
出し、有機層を水20m1.飽和食塩水20m1で洗浄
後、無水硫酸マグネシウムで乾燥した。硫酸マグネシウ
ムをP別技、濃縮乾固した。
Yield: 298.7g Yield: 99.7% GC purity
93% Reference Example 2 3a,8b-cis-2,3,3a,8b-tetrahydro-IH-1,2,5,7-tetrabromocyclopenta[
b] 3.00 g (6°31 mmol) of benzofuran was dissolved in a mixed solvent of THFloml and acetic acid 10 ml, and 0.8657 g (13.2 ml IIol) of zinc was added and stirred at room temperature for 1 hour. The solvent of the liquid was distilled off. 20 ml of water and 20 ml of ethyl acetate were added to the residue for extraction.The aqueous layer was further extracted twice with 20 ml of ethyl acetate, and the organic layer was washed with 20 ml of water and 20 ml of saturated brine, then anhydrous. It was dried with magnesium sulfate.The magnesium sulfate was separated from P and concentrated to dryness.

収量 1. 95g    収率 97.5%GC純度
 96.6% m、p、    108.0〜109.0℃NMR(C
DC1a )δ: 2.90  (2HSm) 、4.48 (IH。
Yield 1. 95g Yield 97.5% GC Purity 96.6% m, p, 108.0-109.0℃ NMR (C
DC1a) δ: 2.90 (2HSm), 4.48 (IH.

m) 、5.60 (IHSm) 、5.80 (2H
Sm) 、7.25 (IHSdS J−2,0Hz)
7.40 (IHS d、J−2,0Hz)I R(K
B r) シcm−’: 3070.2980.2920.1595、1570.
865.830.740.720Mass: 314  (M+) 、316  (M++2) 、3
18  (M” +4) [発明の効果] 本発明によれば、3a、8b−シス−ジヒドロ−3H−
5,7−ジブロモシクロペンタ〔b〕ベンゾフラン(m
)が、3a、8b−シス−ジヒドロ−3H−シクロペン
タ(b)ベンゾフラン(II)から本発明化合物のテト
ラブロモシクロペンタ[b)ベンゾフラン誘導体(I)
を経由することにより、容易にかつ高収率で、再現性よ
く製造できる。従って、(III)の再結晶による単離
精製が可能となり、工業スケールでの(m)の大量合成
が非常に容易になった。
m), 5.60 (IHSm), 5.80 (2H
Sm), 7.25 (IHSdS J-2,0Hz)
7.40 (IHS d, J-2,0Hz) I R (K
B r) cm-': 3070.2980.2920.1595, 1570.
865.830.740.720Mass: 314 (M+), 316 (M++2), 3
18 (M” +4) [Effect of the invention] According to the present invention, 3a,8b-cis-dihydro-3H-
5,7-dibromocyclopenta[b]benzofuran (m
) is 3a,8b-cis-dihydro-3H-cyclopenta (b) benzofuran (II) to the compound of the present invention, tetrabromocyclopenta [b) benzofuran derivative (I)
can be easily produced in high yield and with good reproducibility. Therefore, isolation and purification of (III) by recrystallization became possible, and large-scale synthesis of (m) on an industrial scale became extremely easy.

Claims (2)

【特許請求の範囲】[Claims] (1)式( I )で示される ▲数式、化学式、表等があります▼( I ) テトラブロモシクロペンタ〔b〕ベンゾフラン誘導体。(1) Expressed by formula (I) ▲There are mathematical formulas, chemical formulas, tables, etc.▼(I) Tetrabromocyclopenta[b]benzofuran derivative. (2)式(II)で示される ▲数式、化学式、表等があります▼(II) 3a,8b−シス−ジヒドロ−3H−シクロペンタ〔b
〕ベンゾフランをブロモ化することを特徴とする、請求
項(1)記載の式( I )で示されるテトラブロモシク
ロペンタ〔b〕ベンゾフラン誘導体の製造法。
(2) Shown by formula (II) ▲ There are mathematical formulas, chemical formulas, tables, etc. ▼ (II) 3a,8b-cis-dihydro-3H-cyclopenta[b
] A method for producing a tetrabromocyclopenta[b]benzofuran derivative represented by formula (I) according to claim (1), which comprises brominating benzofuran.
JP1898589A 1989-01-27 1989-01-27 Tetrabromocyclopenta [b] benzofuran derivative and method for producing the same Expired - Lifetime JP2782756B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP1898589A JP2782756B2 (en) 1989-01-27 1989-01-27 Tetrabromocyclopenta [b] benzofuran derivative and method for producing the same

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP1898589A JP2782756B2 (en) 1989-01-27 1989-01-27 Tetrabromocyclopenta [b] benzofuran derivative and method for producing the same

Publications (2)

Publication Number Publication Date
JPH02200683A true JPH02200683A (en) 1990-08-08
JP2782756B2 JP2782756B2 (en) 1998-08-06

Family

ID=11986884

Family Applications (1)

Application Number Title Priority Date Filing Date
JP1898589A Expired - Lifetime JP2782756B2 (en) 1989-01-27 1989-01-27 Tetrabromocyclopenta [b] benzofuran derivative and method for producing the same

Country Status (1)

Country Link
JP (1) JP2782756B2 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108774207A (en) * 2018-07-30 2018-11-09 苏州大学张家港工业技术研究院 Cyclopenta [c] chromene compounds and preparation method thereof

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4830501B2 (en) 2005-02-21 2011-12-07 オムロン株式会社 Substrate inspection method and apparatus, and inspection logic setting method and apparatus thereof

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108774207A (en) * 2018-07-30 2018-11-09 苏州大学张家港工业技术研究院 Cyclopenta [c] chromene compounds and preparation method thereof
CN108774207B (en) * 2018-07-30 2021-12-17 苏州大学张家港工业技术研究院 Cyclopenta [ c ] chromene compounds and process for preparing the same

Also Published As

Publication number Publication date
JP2782756B2 (en) 1998-08-06

Similar Documents

Publication Publication Date Title
US5420310A (en) Conversion of 15-beta to 15-alpha 5,6,7-trinor-4,8-inter-m-phenylene PGI2 derivatives
JPH02200683A (en) Tetrabromocyclopenta(b)benzofuran derivative and production thereof
KR101098201B1 (en) Fluorinated pentacene derivatives and processes for producing these
JP4418048B2 (en) Process for producing 13-cis-retinoic acid
US3354206A (en) 10, 11-dihydro-5-hydroxy-5-vinyl-5h-dibenzo-[a, d] cycloheptenes
JP2782755B2 (en) Method for producing 3a, 8b-cis-dihydro-3H-5,7-dibromocyclopenta [b] benzofuran
JP2000506889A (en) Method for alkylation and smiles rearrangement of hydroxyaromatic compounds
JP2662162B2 (en) Method for producing 3-alkylpyrrole
Wijsman et al. A stereospecific anionic reduction of gem‐bromohalocyclopropanes by the dimsyl anion
KR970001486B1 (en) Preparation of 5,6,7-trinor-4,8-inter-m-phenylene pgi2 derivatives
JPH02200681A (en) Production of 3a,8b-cis-dihydro-3h-cyclopenta(b)-benzofuran
CN116924896A (en) Synthesis method of naphthalenone compound
CN116874359A (en) Synthesis method of naphthalenone compound
JPS63250396A (en) 3'-azido-3'-deoxythymidine derivative
JP3473053B2 (en) Method for producing acetylene alcohols
JPS5857335A (en) Preparation of 2-(1-indanoyl)acetic acid
JP2002060398A (en) Method for producing torgovdienes and estrones
JPH04305548A (en) Halogeno allyl alcohol derivative
JPH0692346B2 (en) Homophthalic acid derivative and its acid anhydride
JPH0535137B2 (en)
JPS6366185A (en) Production of tilivalline
JPS6332778B2 (en)
EP0339815A2 (en) Process for the preparation of pure cis-cyclopropane carboxylic acids and intermediates therefor
JPS61180734A (en) Cyclopentane derivative
JPS60260537A (en) Preparation of unsaturated carboxylic acid ester

Legal Events

Date Code Title Description
FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20080522

Year of fee payment: 10

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20090522

Year of fee payment: 11

EXPY Cancellation because of completion of term
FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20090522

Year of fee payment: 11